Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters











Publication year range
1.
J Immunol ; 211(4): 673-682, 2023 08 15.
Article in English | MEDLINE | ID: mdl-37350632

ABSTRACT

Regulatory T cells (Tregs) contribute to the formation of a tumor-immunosuppressive microenvironment. CCR8 is reportedly selectively expressed in tumor Tregs, and an anti-CCR8 Ab can exert potent antitumor effects by eliminating intratumor Tregs in murine tumor models. In this study, we analyzed changes to intratumor immunity after anti-CCR8 Ab administration, especially in CD8+ T cells, which are involved in cancer cell killing, using the CT26 colorectal carcinoma mouse model. Immunophenotyping of tumor-infiltrating cells by mass cytometry after Ab administration on day 5 of tumor inoculation revealed that CD8+ T cell subsets were dramatically altered in the CCR8 Ab-treated group, with an increase in naive cells and nonexhausted effector cells and a decrease in exhausted cells with high expression levels of TOX. These results were corroborated with flow cytometry analysis. Delayed administration of the anti-CCR8 Ab on day 9 or 12, when the amount of CCR8+ Tregs and CD8+ T cell exhaustion were more progressed, also resulted in a decrease in exhausted CD8+ T cells, leading to tumor regression. Finally, we confirmed that high CCR8+ Treg infiltration was associated with high TOX expression in CD8+ T cells in human cancer patients. In conclusion, administration of an anti-CCR8 Ab can dramatically alter the activation and exhaustion state of intratumor CD8+ T cells, resulting in strong antitumor effects. In cancer patients with an advanced tumor-immunosuppressive environment, CD8+ T cell exhaustion has progressed along with CCR8+ Treg induction. Therefore, targeted depletion of CCR8+ Tregs is expected to be effective in these patients.


Subject(s)
Neoplasms , T-Lymphocytes, Regulatory , Humans , Animals , Mice , CD8-Positive T-Lymphocytes , Immunotherapy/methods , Neoplasms/pathology , Tumor Microenvironment
2.
Proc Natl Acad Sci U S A ; 119(7)2022 02 15.
Article in English | MEDLINE | ID: mdl-35140181

ABSTRACT

Foxp3-expressing CD25+CD4+ regulatory T cells (Tregs) are abundant in tumor tissues. Here, hypothesizing that tumor Tregs would clonally expand after they are activated by tumor-associated antigens to suppress antitumor immune responses, we performed single-cell analysis on tumor Tregs to characterize them by T cell receptor clonotype and gene-expression profiles. We found that multiclonal Tregs present in tumor tissues predominantly expressed the chemokine receptor CCR8. In mice and humans, CCR8+ Tregs constituted 30 to 80% of tumor Tregs in various cancers and less than 10% of Tregs in other tissues, whereas most tumor-infiltrating conventional T cells (Tconvs) were CCR8- CCR8+ tumor Tregs were highly differentiated and functionally stable. Administration of cell-depleting anti-CCR8 monoclonal antibodies (mAbs) indeed selectively eliminated multiclonal tumor Tregs, leading to cure of established tumors in mice. The treatment resulted in the expansion of CD8+ effector Tconvs, including tumor antigen-specific ones, that were more activated and less exhausted than those induced by PD-1 immune checkpoint blockade. Anti-CCR8 mAb treatment also evoked strong secondary immune responses against the same tumor cell line inoculated several months after tumor eradication, indicating that elimination of tumor-reactive multiclonal Tregs was sufficient to induce memory-type tumor-specific effector Tconvs. Despite induction of such potent tumor immunity, anti-CCR8 mAb treatment elicited minimal autoimmunity in mice, contrasting with systemic Treg depletion, which eradicated tumors but induced severe autoimmune disease. Thus, specific removal of clonally expanding Tregs in tumor tissues for a limited period by cell-depleting anti-CCR8 mAb treatment can generate potent tumor immunity with long-lasting memory and without deleterious autoimmunity.


Subject(s)
Immunologic Memory , Neoplasms/metabolism , Receptors, CCR8/metabolism , Animals , Antibodies, Monoclonal , Biomarkers, Tumor , Cell Differentiation , Cell- and Tissue-Based Therapy , Forkhead Transcription Factors/genetics , Forkhead Transcription Factors/metabolism , Gene Deletion , Gene Expression Regulation, Neoplastic , Humans , Mice , Receptors, CCR8/genetics , T-Lymphocytes, Regulatory
3.
J Am Soc Nephrol ; 20(7): 1504-12, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19406976

ABSTRACT

Excessive dietary phosphorus may increase cardiovascular risk in healthy individuals as well as in patients with chronic kidney disease, but the mechanisms underlying this risk are not completely understood. To determine whether postprandial hyperphosphatemia may promote endothelial dysfunction, we investigated the acute effect of phosphorus loading on endothelial function in vitro and in vivo. Exposing bovine aortic endothelial cells to a phosphorus load increased production of reactive oxygen species, which depended on phosphorus influx via sodium-dependent phosphate transporters, and decreased nitric oxide production via inhibitory phosphorylation of endothelial nitric oxide synthase. Phosphorus loading inhibited endothelium-dependent vasodilation of rat aortic rings. In 11 healthy men, we alternately served meals containing 400 mg or 1200 mg of phosphorus in a double-blind crossover study and measured flow-mediated dilation of the brachial artery before and 2 h after the meals. The high dietary phosphorus load increased serum phosphorus at 2 h and significantly decreased flow-mediated dilation. Flow-mediated dilation correlated inversely with serum phosphorus. Taken together, these findings suggest that endothelial dysfunction mediated by acute postprandial hyperphosphatemia may contribute to the relationship between serum phosphorus level and the risk for cardiovascular morbidity and mortality.


Subject(s)
Endothelium, Vascular/drug effects , Endothelium, Vascular/physiopathology , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Phosphorus, Dietary/pharmacology , Adult , Animals , Brachial Artery/drug effects , Brachial Artery/physiology , Cardiovascular Diseases/epidemiology , Cattle , Cells, Cultured , Cross-Over Studies , Disease Models, Animal , Double-Blind Method , Endothelium, Vascular/cytology , Humans , Hyperphosphatemia/blood , Hyperphosphatemia/complications , Male , Nitric Oxide Synthase Type III/metabolism , Phosphorus/blood , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Regional Blood Flow/drug effects , Risk Factors , Vasodilation/drug effects
4.
Bone ; 41(1): 52-8, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17448744

ABSTRACT

Caveolin-1 is an essential and signature protein of caveolae, which are small invaginations of the plasma membrane enriched in cholesterol and sphingolipids. Although high levels of expression of caveolin-1 have been demonstrated in osteoblasts as well as endothelial cells, fibroblasts, and muscular cells, the role of caveolin-1 in osteoblasts has not been clarified. Here, we show that caveolin-1 is secreted from osteoblasts in the form of matrix vesicles; extracellular vesicles released from the plasma membrane of osteoblasts. In this study, caveolae and matrix vesicles were similarly enriched in cholesterol and sphingomyelin in fractions isolated from mineralizing MC3T3-E1 cells. Interestingly, in the MC3T3-E1 cells caveolin-1 was enriched in the matrix vesicle fraction as well as the caveolar membrane fraction, and the amount of caveolin-1 in the matrix vesicle fraction increased as differentiation progressed. Localization of caveolin-1 in matrix vesicles was also confirmed in murine tibia. Furthermore, overexpression of caveolin-1 enhanced matrix calcification in MC3T3-E1 cells, whereas knockdown of caveolin-1 diminished it. These results suggest that secreted caveolin-1 as a component of matrix vesicles may play an important role in osteoblast calcification.


Subject(s)
Caveolin 1/metabolism , Osteoblasts/metabolism , 3T3 Cells , Alkaline Phosphatase/metabolism , Animals , Base Sequence , Calcification, Physiologic , Caveolin 1/antagonists & inhibitors , Caveolin 1/genetics , Cell Differentiation , Cholesterol/metabolism , DNA Primers/genetics , Extracellular Matrix/metabolism , Gene Expression , Mice , Microscopy, Immunoelectron , Osteoblasts/ultrastructure , Phosphates/metabolism , RNA Interference , Secretory Vesicles/metabolism , Sphingomyelins/metabolism , Tibia/metabolism , Tibia/ultrastructure
5.
Toxicology ; 227(3): 248-61, 2006 Oct 29.
Article in English | MEDLINE | ID: mdl-16962226

ABSTRACT

Stress, such as trauma and injury, is known to cause transcriptional changes in various tissues; however, there is little information on tissue-specific gene expression in response to stress. Here, we have examined duodenal gene expression in rats subjected to whole-body immobilization in order to elucidate the mechanism underlying the stress response in the duodenum--one of the tissues that is most sensitive to external stress. DNA microarray analysis revealed that the immobilization for 2 weeks caused great changes in gene expression in the rat duodenum: 165 genes exhibited more than a two-fold change in expression level (103 up-regulated; 62 down-regulated). In addition, functional classification of these genes showed that immobilization preferentially stimulated the expression of genes related to lipid metabolism, including genes encoding mitochondrial HMG-CoA synthase, a key enzyme in ketogenesis; solute carrier 27A2, a fatty acid transporter; and dienoyl CoA reductase, a key enzyme in beta-oxidation. To elucidate the factors mediating these immobilization-induced changes, we treated rats and small intestinal IEC-6 cells with dexamethasone and hydrogen peroxide. In both rats and IEC-6 cells, treatment with dexamethasone induced changes in gene expression that mimicked the immobilization-mediated increase in expression of the mitochondrial HMG-CoA synthase and dienoyl CoA reductase transcripts, suggesting that stress-induced synthesis of glucocorticoid hormones mediates, at least in part, the stress response in the duodenum. These results suggest that immobilization may alter lipid metabolism in the small intestine by modifying the expression of specific genes through which the small intestine may seek to protect itself from stress-induced damage.


Subject(s)
Duodenum/metabolism , Gene Expression , Lipid Metabolism/genetics , Stress, Psychological/metabolism , Animals , Cell Line , Dexamethasone/pharmacology , Down-Regulation , Duodenum/enzymology , Hydrogen Peroxide/pharmacology , Male , Mitochondria/enzymology , Mitochondria/metabolism , Oligonucleotide Array Sequence Analysis , Rats , Rats, Wistar , Restraint, Physical , Reverse Transcriptase Polymerase Chain Reaction , Stress, Psychological/enzymology , Stress, Psychological/genetics , Up-Regulation
6.
J Bone Miner Metab ; 24(4): 291-9, 2006.
Article in English | MEDLINE | ID: mdl-16816923

ABSTRACT

Immobilization induces significant and progressive bone loss, with an increase in urinary excretion and a decrease in intestinal absorption of calcium. These actions lead to negative calcium balance and the development of disuse osteoporosis. The aims of this study were to evaluate the molecular mechanisms of decreased intestinal calcium absorption and to determine the effect of dietary 1,25-dihydroxyvitamin D [1,25(OH)2D] and a high-calcium diet on bone loss due to immobilization. The immobilized rat model was developed in the Bollman cage III to induce systemic disuse osteoporosis in the animals. There was a significant decrease in lumbar bone mineral density (BMD) and intestinal calcium absorption in the immobilized group compared with the controls. Serum 25-hydroxyvitamin D concentration did not change, but 1,25(OH)2D concentration decreased significantly. The mRNA levels of renal 25-hydoxyvitamin D 24-hydroxylase (24OHase) increased, whereas those of renal 25-hydroxyvitamin D 1-alpha hydroxylase (1alpha-hydroxylase), duodenal transient receptor potential cation channel, subfamily V, member 6 (TRPV6), TRPV5, and calbindin-D9k were all decreased. A high-calcium diet did not prevent the reduction in lumbar BMD or affect the mRNA expression of proteins related to calcium transport. Dietary administration of 1,25(OH)2D increased the intestinal calcium absorption that had been downregulated by immobilization. TRPV6, TRPV5, and calbindin-D9k mRNA levels were also upregulated, resulting in prevention of the reduction in lumbar BMD. Therefore, it is concluded that dietary 1,25(OH)2D prevented decreases in intestinal calcium absorption and simultaneously prevented bone loss in immobilized rats. However, it remains unclear that calcium absorption and expression of calcium transport proteins are essential for the regulation of lumbar BMD.


Subject(s)
Calcium/metabolism , Dihydroxycholecalciferols/metabolism , Duodenum/metabolism , Immobilization/adverse effects , Intestinal Absorption , Animals , Calcium, Dietary , Humans , Rats , Rats, Wistar/metabolism
8.
J Med Invest ; 52 Suppl: 295-6, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16366519

ABSTRACT

Oxidative stress has emerged as an important pathogenic factor in the development of long-term complications, such as hypertension, atherosclerosis, nephropathy, and cancer. Taking many antioxidants from natural food may be effective to prevent us from those diseases. We have attempted to evaluate the effect of improvement by dietary antioxidants on the endothelial dysfunction induced by hyperglycemia. Fluorescence indicators for reactive oxygen species and nitric oxide were employed to the evaluation. The combination of those fluorescence indicators could be powerful tool to evaluate the effect of anti-stress nutrients on both oxidative stress and endothelial dysfunction.


Subject(s)
Antioxidants/analysis , Endothelium, Vascular/drug effects , Glucose/pharmacology , Oxidative Stress , Animals , Antioxidants/metabolism , Aorta, Thoracic/cytology , Cattle , Cell Culture Techniques , Cells, Cultured , Dose-Response Relationship, Drug , Endothelium, Vascular/metabolism , Fluorescent Dyes , Hyperglycemia/metabolism , Microscopy, Confocal , Nitric Oxide/metabolism , Reactive Oxygen Species/metabolism , Time Factors
9.
Kidney Int ; 68(3): 1137-47, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16105044

ABSTRACT

BACKGROUND: Parathyroid hormone (PTH) rapidly down-regulates type IIa sodium-dependent phosphate transporter (NaPi-IIa) via an endocytic pathway. Since the relationship between PTH signaling and NaPi-IIa endocytosis has not been explored, we investigated the role of membrane microdomains in this process. METHODS: We examined the submembrane localization of NaPi-IIa in opossum kidney (OK-N2) cells that stably expressed human NaPi-IIa, and searched for a PTH-induced specific phosphorylating substrate on their membrane microdomains by immunoblotting with specific antibody against phospho substrates of protein kinases. RESULTS: We found that NaPi-IIa was primarily localized in low-density membrane (LDM) domains of the plasma membrane; PTH reduced the levels of immunoreactive NaPi-IIa in these domains. Furthermore, PTH activated both protein kinase A (PKA) and protein kinase Calpha (PKCa) and increased the phosphorylation of 250 kD and 80 kD substrates; this latter substrate was identified as ezrin, which a member of the ezrin-radixin-moesin (ERM) protein family. In response to PTH, ezrin was phosphorylated by both PKA and PKC. Dominant negative ezrin blocked the reduction in NaPi-IIa expression in the LDM domains that was induced by PTH. CONCLUSION: These data suggest that NaPi-IIa and PTH-induced phosphorylated proteins that include ezrin are compartmentalized in LDM microdomains. This compartmentalization may play an important role in the down-regulation of NaPi-IIa via endocytosis.


Subject(s)
Cell Compartmentation/physiology , Endocytosis/physiology , Kidney/cytology , Parathyroid Hormone/pharmacology , Sodium-Phosphate Cotransporter Proteins, Type IIa/metabolism , Animals , Antineoplastic Agents/pharmacology , Cell Line , Chlorpromazine/pharmacology , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclodextrins/pharmacology , Cytochalasin D/pharmacology , Cytoskeletal Proteins , Dopamine Antagonists/pharmacology , Down-Regulation/drug effects , Humans , Immunohistochemistry , Nocodazole/pharmacology , Nucleic Acid Synthesis Inhibitors/pharmacology , Opossums , Phosphates/metabolism , Phosphoproteins/genetics , Phosphoproteins/metabolism , Phosphorylation/drug effects , Protein Kinase C-alpha/metabolism , Protein Structure, Tertiary , Sodium-Phosphate Cotransporter Proteins, Type IIa/chemistry , Sodium-Phosphate Cotransporter Proteins, Type IIa/genetics
10.
J Cell Mol Med ; 8(2): 191-200, 2004.
Article in English | MEDLINE | ID: mdl-15256067

ABSTRACT

Inorganic phosphate (Pi) is required for cellular function and skeletal mineralization. Serum Pi level is maintained within a narrow range through a complex interplay between intestinal absorption, exchange with intracellular and bone storage pools, and renal tubular reabsorption. The crucial regulated step in Pi homeostasis is the transport of Pi across the renal proximal tubule. Type II sodium-dependent phosphate (Na/Pi) cotransporter (NPT2) is the major molecule in the renal proximal tubule and is regulated by Pi, parathyroid hormone and by 1,25-dihydroxyvitamin D. Recent studies of inherited and acquired hypophosphatemia [X-linked hypophosphatemic rickets/osteomalacia (XLH), autosomal dominant hypophosphatemic rickets/osteomalacia (ADHR) and tumor-induced rickets/osteomalacia (TIO)], which exhibit similar biochemical and clinical features, have led to the identification of novel genes, PHEX and FGF23, that play a role in the regulation of Pi homeostasis. The PHEX gene, which is mutated in XLH, encodes an endopeptidase, predominantly expressed in bone and teeth, but not in kidney. FGF-23 may be a substrate of this endopeptidase and may therefore accumulate in patients with XLH. In the case of ADHR mutations in the furin cleavage site, which prevent the processing of FGF-23 into fragments, lead to the accumulation of a "stable" circulating form of the peptide which also inhibits renal Pi reabsorption. In the case of TIO, ectopic overproduction of FGF-23 overwhelms its processing and degradation by PHEX, leading to the accumulation of FGF-23 in the circulation and inhibition of renal Pi reabsorption. Mice homozygous for severely hypomorphic alleles of the Klotho gene exhibit a syndrome resembling human aging, including atherosclerosis, osteoporosis, emphysema, and infertility. The KLOTHO locus is associated with human survival, defined as postnatal life expectancy, and longevity, defined as life expectancy after 75. In considering the relationship of klotho expression to the dietary Pi level, the klotho protein seemed to be negatively controlled by dietary Pi.


Subject(s)
Diet , Homeostasis , Phosphates/metabolism , Phosphates/pharmacology , Animals , Fibroblast Growth Factor-23 , Homeostasis/drug effects , Humans , Hypophosphatemia, Familial/metabolism , Osteomalacia/metabolism , Phosphates/administration & dosage
11.
Biosci Biotechnol Biochem ; 68(3): 508-15, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15056880

ABSTRACT

Modulation of the activity and content of cytochrome P-450 (CYP) in hepatic microsomes may be important to human health since these enzymes activate and inactivate a wide range of xenobiotics and food components. Regulation of the inducibility of most CYPs involves transcriptional regulation and post-transcriptional mRNA stabilization. We examined in the present study the effect of dietary soy isoflavone (0-300 mg of isoflavone/kg of diet) on the mRNA abundance of rat hepatic CYP1A1, CYP1A2, CYP2B1/2, CYP2C11, CYP2E1, CYP3A1, CYP3A2 and CYP4A1 by quantitative competitive RT-PCR and real-time monitored RT-PCR. A fermented soy extract containing 155 mg/g of genistein, 127 mg/g of daidzein, and other minor isoflavones was used as the isoflavone source. The dietary soy isoflavone had no affect on the hepatic mRNA abundance of these CYPs. The results by both methods were well matched and indicate that the dietary soy isoflavone did not cause the induction of CYPs by transcriptional step-up regulation or post-transcriptional mRNA stabilization.


Subject(s)
Cytochrome P-450 Enzyme System/biosynthesis , Glycine max/chemistry , Isoflavones/pharmacology , Liver/enzymology , Animals , Body Weight/drug effects , Cyclophilins/drug effects , Cyclophilins/genetics , Cyclophilins/metabolism , Cytochrome P-450 Enzyme System/genetics , Eating/drug effects , Enzyme Induction , Female , Indoles/pharmacology , Isoenzymes/drug effects , Isoenzymes/genetics , Isoenzymes/metabolism , Isoflavones/metabolism , Liver/drug effects , Liver/metabolism , Male , Plant Extracts/chemistry , Plant Extracts/pharmacology , RNA Stability , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Glycine max/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL